{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:15:22Z","timestamp":1783116922789,"version":"3.54.6"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korea Institute of Startup and Entrepreneurship Development","award":["10313246"],"award-info":[{"award-number":["10313246"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-025-00685-9","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T09:12:22Z","timestamp":1743757942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides"],"prefix":"10.1186","volume":"26","author":[{"given":"Shahnaz","family":"Begum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Jamil","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Su","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Na","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hyeob","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"685_CR1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/ITT.S266409","volume":"10","author":"P Suchonwanit","year":"2021","unstructured":"Suchonwanit P, Kositkuljorn C, Pomsoong C. Alopecia Areata: an autoimmune disease of multiple players. ImmunoTargets Therapy. 2021;10:299\u2013312.","journal-title":"ImmunoTargets Therapy"},{"key":"685_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","volume":"78","author":"LC Strazzulla","year":"2018","unstructured":"Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, et al. Alopecia Areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78:1\u201312.","journal-title":"J Am Acad Dermatol"},{"key":"685_CR3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","volume":"20","author":"L Xing","year":"2014","unstructured":"Xing L, Dai Z, Jabbari A, Cerise JE, Higgins CA, Gong W, et al. Alopecia Areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med. 2014;20:1043\u20139.","journal-title":"Nat Med"},{"key":"685_CR4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1517\/14656561003752730","volume":"11","author":"D Rathnayake","year":"2010","unstructured":"Rathnayake D, Sinclair R. Male androgenetic alopecia. Expert Opin Pharmacother. 2010;11:1295\u2013304.","journal-title":"Expert Opin Pharmacother"},{"key":"685_CR5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/17469872.1.2.261","volume":"1","author":"L Yip","year":"2006","unstructured":"Yip L, Sinclair RD. Antiandrogen therapy for androgenetic alopecia. Expert Rev Dermatol. 2006;1:261\u20139.","journal-title":"Expert Rev Dermatol"},{"key":"685_CR6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2018.12.001","volume":"98","author":"T Simakou","year":"2019","unstructured":"Simakou T, Butcher JP, Reid S, Henriquez FL. Alopecia Areata: a multifactorial autoimmune condition. J Autoimmun. 2019;98:74\u201385.","journal-title":"J Autoimmun"},{"key":"685_CR7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/exd.14155","volume":"29","author":"M Bertolini","year":"2020","unstructured":"Bertolini M, McElwee K, Gilhar A, Bulfone-Paus S, Paus R. Hair follicle immune privilege and its collapse in Alopecia Areata. Exp Dermatol. 2020;29:703\u201325.","journal-title":"Exp Dermatol"},{"key":"685_CR8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jid.2017.09.046","volume":"138","author":"A Tafazzoli","year":"2018","unstructured":"Tafazzoli A, Forstner AJ, Broadley D, Hofmann A, Redler S, Petukhova L, et al. Genome-wide MicroRNA analysis implicates miR-30b\/d in the etiology of Alopecia Areata. J Invest Dermatology. 2018;138:549\u201356.","journal-title":"J Invest Dermatology"},{"key":"685_CR9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/exd.12785","volume":"24","author":"T Andl","year":"2015","unstructured":"Andl T, Botchkareva NV. MicroRNAs (miRNAs) in the control of HF development and cycling: the next frontiers in hair research. Exp Dermatol. 2015;24:821\u20136.","journal-title":"Exp Dermatol"},{"key":"685_CR10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/gene.2017.4","volume":"18","author":"EHC Wang","year":"2017","unstructured":"Wang EHC, Destefano GM, Patel AV, Drill E, Harel S, Cela C, et al. Identification of differentially expressed miRNAs in Alopecia Areata that target immune-regulatory pathways. Genes Immun. 2017;18:100\u20134.","journal-title":"Genes Immun"},{"key":"685_CR11","doi-asserted-by":"crossref","first-page":"104589","DOI":"10.1016\/j.yexmp.2020.104589","volume":"118","author":"W Deng","year":"2021","unstructured":"Deng W, Hu T, Han L, Liu B, Tang X, Chen H, et al. miRNA microarray profiling in patients with androgenic alopecia and the effects of miR-133b on hair growth. Exp Mol Pathol. 2021;118:104589.","journal-title":"Exp Mol Pathol"},{"key":"685_CR12","doi-asserted-by":"crossref","unstructured":"Deng W, Hu T, Han L, Liu B, Tang X, Chen H et al. miRNA microarray profiling in patients with androgenic alopecia and the effects of miR-133b on hair growth. Exp Mol Pathol. 2021;118 July 2020:104589.","DOI":"10.1016\/j.yexmp.2020.104589"},{"key":"685_CR13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s11739-016-1482-y","volume":"11","author":"M Becatti","year":"2016","unstructured":"Becatti M, Barygina V, Emmi G, Silvestri E, Taddei N, Lotti T, et al. SIRT1 activity is decreased in lesional psoriatic skin. Intern Emerg Med. 2016;11:891\u20133.","journal-title":"Intern Emerg Med"},{"key":"685_CR14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1615\/CritRevOncog.2014012374","volume":"20","author":"H Yang","year":"2015","unstructured":"Yang H, Bi YJ, Xue LX, Wang J, Lu Y, Zhang ZG, et al. Multifaceted modulation of SIRT1 in cancer and inflammation. Crit Rev Oncog. 2015;20:49\u201364.","journal-title":"Crit Rev Oncog"},{"key":"685_CR15","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1128\/MCB.00289-06","volume":"26","author":"M Fu","year":"2006","unstructured":"Fu M, Liu M, Sauve AA, Jiao X, Zhang X, Wu X, et al. Hormonal Control of Androgen Receptor Function through SIRT1. Mol Cell Biol. 2006;26:8122\u201335.","journal-title":"Mol Cell Biol"},{"key":"685_CR16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2023.05.005","volume":"111","author":"L Hao","year":"2023","unstructured":"Hao L, Nam K-H, Lee G-J, Kim D, Shin J-M, Lee Y, et al. SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of Alopecia Areata. J Dermatol Sci. 2023;111:2\u20139.","journal-title":"J Dermatol Sci"},{"key":"685_CR17","doi-asserted-by":"crossref","unstructured":"Koh HS, Lee S, Lee HJ, Min J, Iwatsubo T, Teunissen CE et al. Targeting MicroRNA-485-3p Blocks Alzheimer \u2019 s Disease Progression. 2021.","DOI":"10.3390\/ijms222313136"},{"key":"685_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.lfs.2018.10.003","volume":"212","author":"J Liu","year":"2018","unstructured":"Liu J, Xu Y, Wu Q, Ding Q, Fan W. Sirtuin-1 protects hair follicle stem cells from TNF\u03b1-mediated inflammatory stress via activating the MAPK-ERK-Mfn2 pathway. Life Sci. 2018;212:213\u201324.","journal-title":"Life Sci"},{"key":"685_CR19","doi-asserted-by":"crossref","unstructured":"Shin JM, Choi DK, Sohn KC, Kim SY, Min Ha J, Lee YH et al. Double-stranded RNA induces inflammation via the NF-? B pathway and inflammasome activation in the outer root sheath cells of hair follicles. Sci Rep. 2017;7.","DOI":"10.1038\/srep44127"},{"key":"685_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jdermsci.2021.04.009","volume":"102","author":"K Hashimoto","year":"2021","unstructured":"Hashimoto K, Yamada Y, Sekiguchi K, Matsuda S, Mori S, Matsumoto T. Induction of Alopecia Areata in C3H\/HeJ mice using cryopreserved lymphocytes. J Dermatol Sci. 2021;102:177\u201383.","journal-title":"J Dermatol Sci"},{"key":"685_CR21","doi-asserted-by":"crossref","unstructured":"Shin JM, Choi DK, Sohn KC, Koh JW, Lee YH, Seo YJ, et al. Induction of Alopecia Areata in C3H\/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma. Sci Rep. 2018;8:2\u20139.","DOI":"10.1038\/s41598-018-30997-3"},{"key":"685_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jdermsci.2020.11.002","volume":"101","author":"P Mohammadi","year":"2021","unstructured":"Mohammadi P, Nilforoushzadeh MA, Youssef KK, Sharifi-Zarchi A, Moradi S, Khosravani P, et al. Defining microRNA signatures of hair follicular stem and progenitor cells in healthy and androgenic alopecia patients. J Dermatol Sci. 2021;101:49\u201357.","journal-title":"J Dermatol Sci"},{"key":"685_CR23","doi-asserted-by":"crossref","unstructured":"Papukashvili D, Rcheulishvili N, Liu C, Xie F, Tyagi D, He Y et al. Perspectives on mirnas targeting dkk1 for developing hair regeneration therapy. 2021.","DOI":"10.3390\/cells10112957"},{"key":"685_CR24","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","volume":"174","author":"XX Wang","year":"2016","unstructured":"Wang XX, Wang QQ, Wu JQ, Jiang M, Chen L, Zhang CF, et al. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo. Br J Dermatol. 2016;174:1318\u201326.","journal-title":"Br J Dermatol"},{"key":"685_CR25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","volume":"13","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun rev. 2014;13:272\u201380.","journal-title":"Autoimmun rev"},{"key":"685_CR26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4049\/jimmunol.1501798","volume":"197","author":"Z Dai","year":"2016","unstructured":"Dai Z, Xing L, Cerise J, Wang EHC, Jabbari A, de Jong A, et al. CXCR3 blockade inhibits T Cell Migration into the skin and prevents development of Alopecia Areata. J Immunol. 2016;197:1089\u201399.","journal-title":"J Immunol"},{"key":"685_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.89790","volume":"1","author":"J Mackay-Wiggan","year":"2016","unstructured":"Mackay-Wiggan J, Jabbari A, Nguyen N, Cerise JE, Clark C, Ulerio G, et al. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe Alopecia Areata. JCI Insight. 2016;1:1\u20139.","journal-title":"JCI Insight"},{"key":"685_CR28","first-page":"1","volume":"6","author":"Z Dai","year":"2021","unstructured":"Dai Z, Chen J, Chang Y, Christiano AM. Selective inhibition of JAK3 signaling is sufficient to reverse Alopecia Areata. JCI Insight. 2021;6:1\u201313.","journal-title":"JCI Insight"},{"key":"685_CR29","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/ijd.14192","volume":"57","author":"L Bokhari","year":"2018","unstructured":"Bokhari L, Sinclair R. Treatment of alopecia universalis with topical Janus kinase inhibitors \u2013 a double blind, placebo, and active controlled pilot study. Int J Dermatol. 2018;57:1464\u201370.","journal-title":"Int J Dermatol"},{"key":"685_CR30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08916934.2011.637532","volume":"45","author":"A Pontillo","year":"2012","unstructured":"Pontillo A, Girardelli M, Kamada AJ, Pancotto JAT, Donadi EA, Crovella S, et al. Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity. 2012;45:271\u20138.","journal-title":"Autoimmunity"},{"key":"685_CR31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clim.2012.12.006","volume":"147","author":"SL Masters","year":"2013","unstructured":"Masters SL. Specific inflammasomes in complex diseases. Clin Immunol. 2013;147:223\u20138.","journal-title":"Clin Immunol"},{"key":"685_CR32","unstructured":"Tsan M-F, Gao B. Heat Shock Protein and Innate Immunity. 2004."},{"key":"685_CR33","doi-asserted-by":"crossref","unstructured":"Routsias JG, Tzioufas AG. The role of chaperone proteins in autoimmunity. Annals of the New York Academy of Sciences. Blackwell Publishing Inc.; 2006. pp. 52\u201364.","DOI":"10.1196\/annals.1366.029"},{"key":"685_CR34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1535-7163.MCT-18-0432","volume":"18","author":"J Dong","year":"2019","unstructured":"Dong J, Wu Z, Wang D, Pascal LE, Nelson JB, Wipf P, et al. Hsp70 binds to the androgen receptor N-terminal domain and modulates the receptor function in prostate cancer cells. Mol Cancer Ther. 2019;18:39\u201350.","journal-title":"Mol Cancer Ther"},{"key":"685_CR35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1755-148X.2011.00916.x","volume":"25","author":"JA Mosenson","year":"2012","unstructured":"Mosenson JA, Zloza A, Klarquist J, Barfuss AJ, Guevara-Patino JA, Le Poole IC. HSP70i is a critical component of the immune response leading to vitiligo. Pigment Cell Melanoma Res. 2012;25:88\u201398.","journal-title":"Pigment Cell Melanoma Res"},{"key":"685_CR36","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s12192-010-0209-7","volume":"15","author":"TC Wikramanayake","year":"2010","unstructured":"Wikramanayake TC, Alvarez-Connelly E, Simon J, Mauro LM, Guzman J, Elgart G, et al. Heat treatment increases the incidence of Alopecia Areata in the C3H\/HeJ mouse model. Cell Stress Chaperones. 2010;15:985\u201391.","journal-title":"Cell Stress Chaperones"},{"key":"685_CR37","doi-asserted-by":"crossref","unstructured":"Zhou XL, Xu JJ, Ni YH, Chen XC, Zhang HX, Zhang XM et al. SIRT1 activator (SRT1720) improves the follicle reserve and prolongs the ovarian lifespan of diet-induced obesity in female mice via activating SIRT1 and suppressing mTOR signaling. J Ovarian Res. 2014;7.","DOI":"10.1186\/s13048-014-0097-z"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00685-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-025-00685-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00685-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:59:21Z","timestamp":1743814761000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-025-00685-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1186\/s12865-025-00685-9","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experimentation conducted in this study adhered to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and was approved by the Institutional Animal Care and Use Committee (IACUC) of Biorchestra (permit numbers: BOIACUC-20230531-0002, BOIACUC-20220908-0001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}